Welcome To The BlockRx™ Token Sale

BlockRx

Blog

A contract by any other name is still a contract. In essence, they are legal agreements between two parties. Josh Stark, a lawyer at Ledger Labs, had defined Smart Contracts as:” The use of computer code to articulate, verify and execute an agreement between parties. Whereas a typical contract is drafted using natural language, the…

Read More

Over the last year, we have spoken to many different organizations about their vision for using ADLT™.  In many cases, their challenges lie around bridging systems that don’t easily communicate with each other and data security/integrity. The challenges for the management of clinical trials are the same. One of the first challenges those coordinating clinical…

Read More

In an effort to support the Pharma community, iSolve has developed a presentation and demo to help Pharma Manufacturers, Wholesalers, API Providers and Retailers, understand the concepts of the Blockchain and understand how the Blockchain and ADLT™ can support their business initiatives. Our presentation and demo provides a visual understanding of how our ADLT™ solution…

Read More

Recently, I began reading a book called Only Humans Need Apply. The book focuses on the next technology revolution “Cognitive Computing”, which encompasses big data, deep learning, neural networks, automation, and AI, and its threat to knowledge workers. The one point that stuck out in my mind is that all of these technologies are potentially…

Read More

Finally, 2017!  For those of us involved in Blockchain Pharma initiatives, 2017 is going to be a very exciting and challenging year!  The Pharma industry, which include Providers, Manufacturers, Wholesalers, 3PL and Retailers are working diligently to expand their Blockchain footprint by leveraging additional business units to utilize the Blockchain  as a method to provide…

Read More

The Drug Development Chain (Discoveryà R&D-à Pre-Clinical testingà Clinical Testingà Regulatory ApprovalàMarket Release) is the long, arduous, and expensive process that a therapy takes from idea to cure. The process requires experts from a broad spectrum of disciplines and the ability to collect, analyze, and collate data housed in multiple internal and external systems that…

Read More

All people require some type of motivation to perform well at work or school. Some are motivated by public recognition, frequent flyer miles, the feeling of overcoming a challenge, or even a nice evening out. What is less obvious is that people require incentives to maintain a healthy lifestyle or improve adherence. It would seem…

Read More

As the biopharma industry moves toward personalized medicine, there will be a greater need to exchange patient data with organizations that are not part of the “traditional” healthcare team. The concern being that such data, if centralized like credit card information, could become a target for a cyberattack. Imagine, for example, a high profile business…

Read More

Investors face multiple challenges in identifying the right portfolio company for their funds. Currently, only about 1/3rd of investments return the 3.5-5x Cash on Cash returns expected of a successful VC firm. On the other side of the coin, companies have a difficult time connecting with the right investors and Investment Associates spend a lot…

Read More

According to the Pharmaceutical Research and Manufacturers of America (PhRMA), it costs on average of $2.6 billion and takes 10-15 years to bring a new medication to market. This is a lengthy and complex process. Throughout the Therapeutic Development Lifecycle, there is a need for a wide range of expertise, financing, and IP to accomplish…

Read More